Heidelberg Pharma AG (ETR:HPHA) | Finanzwire

Basculer en Français

9562	Companies
188958	Keywords
120655	Articles
100824	Press releases

Home
Companies
Heidelberg Pharma AG

BRIEF

published on 05/15/2025 at 14:36, 7 months 6 days ago

Heidelberg Pharma Announces AGM Results and New Supervisory Board

Supervisory Board Biotech Heidelberg Pharma ADCs AGM 2025
PRESS RELEASE

published on 05/15/2025 at 14:31, 7 months 6 days ago

Heidelberg Pharma Reports on the Results of the Ordinary Annual General Meeting 2025 and New Supervisory Board
Heidelberg Pharma AG reports on the results of the Ordinary Annual General Meeting 2025 and the appointment of a new Supervisory Board. Key decisions made include new board members and Dr. Karl Benedikt Biesinger elected as Chairman

Annual General Meeting Supervisory Board Heidelberg Pharma AG ADCs Dr. Karl Benedikt Biesinger
BRIEF

published on 05/14/2025 at 18:45, 7 months 7 days ago

Heidelberg Pharma to Unveil Clinical Data on HDP-101 at EHA 2025

Clinical Trial Heidelberg Pharma HDP-101 Multiple Myeloma EHA 2025
PRESS RELEASE

published on 05/14/2025 at 18:40, 7 months 7 days ago

Heidelberg Pharma to Present Promising New Clinical Data on its Lead ATAC Candidate HDP-101 at EHA 2025
Heidelberg Pharma to present new clinical data on lead ATAC candidate HDP-101 at EHA 2025. Promising results in Multiple Myeloma treatment. R&D webinar to follow

Clinical Data Heidelberg Pharma Multiple Myeloma ATAC Candidate EHA 2025
BRIEF

published on 04/24/2025 at 07:21, 7 months 28 days ago

Heidelberg Pharma AG's First Quarter Financial Report for 2025

Financial Statement Clinical Trials Heidelberg Pharma 2025 Outlook ADC Programs
PRESS RELEASE

published on 04/24/2025 at 07:16, 7 months 28 days ago

Heidelberg Pharma AG: Interim Statement on the First Three Months of Financial Year 2025
Heidelberg Pharma AG reports positive results for ATAC candidates HDP-101 and HDP-102 in Q1 2025, extends cash reach through financing activities, and progresses towards market approval for TLX250-CDx

HDP-101 Heidelberg Pharma AG TLX250-CDx ATAC Candidates HDP-102
BRIEF

published on 03/26/2025 at 09:28, 8 months 27 days ago

Heidelberg Pharma to Showcase ADC Innovations at AACR 2025

Heidelberg Pharma ADC Technology HDP-201 AACR 2025 NAMPT Inhibitors
PRESS RELEASE

published on 03/26/2025 at 09:23, 8 months 27 days ago

Heidelberg Pharma to Present Data from its ADC Technology Platforms at AACR Annual Meeting 2025
Heidelberg Pharma AG to present latest ADC research results and advancements at AACR Annual Meeting 2025, showcasing Exatecan-based and Amanitin-based ADC technology platforms

Heidelberg Pharma ADC AACR Annual Meeting 2025 Exatecan-based ADC Amanitin-based ADC
BRIEF

published on 03/21/2025 at 07:12, 9 months 1 day ago

Heidelberg Pharma Reports 2024 Financial Results and Clinical Progress

Clinical Trials Heidelberg Pharma ADC Technology Multiple Myeloma 2024 Financial Results
PRESS RELEASE

published on 03/21/2025 at 07:07, 9 months 1 day ago

Heidelberg Pharma announces financial figures and reports on successful business performance in 2024
Heidelberg Pharma AG reports successful business performance in 2024 with improved financial figures including clinical trial results for HDP-101 in multiple myeloma and upcoming study for HDP-102. Financial outlook and strategy for 2025 highlighted

Financial Results Clinical Trial Heidelberg Pharma AG 2025 Outlook ATAC Technology

Accesswire

Published on 12/22/2025 at 08:05, 2 hours 3 minutes ago

Tocvan Begins Trenching Material for the Pilot Mine and Pushes Ahead With Infrastructure Development
Published on 12/20/2025 at 00:30, 2 days 9 hours ago

Alphinat Announces a Profit of $120,155 for Fiscal Year Ended August 31, 2025
Published on 12/19/2025 at 22:00, 2 days 12 hours ago

GMV Minerals Inc. Closes Non-Brokered Equity Financing
Published on 12/19/2025 at 18:30, 2 days 15 hours ago

Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Published on 12/19/2025 at 14:40, 2 days 19 hours ago

Northern Superior Announces Closing of the Arrangement

View all ACCESSWIRE

EQS Group

Published on 12/22/2025 at 09:30, 38 minutes ago

Huawei's MoM-based Multi-Agent Collaboration System Empowers Core Networks' Transitioning to L4 High Stability
Published on 12/22/2025 at 09:22, 46 minutes ago

Heirs Energies Agrees $750m Afreximbank Financing to Drive Long-Term Growth
Published on 12/22/2025 at 09:19, 49 minutes ago

INDUS acquires media technology specialist
Published on 12/22/2025 at 09:00, 1 hour 7 minutes ago

Original-Research: Cantourage Group SE (von NuWays AG): BUY
Published on 12/22/2025 at 09:00, 1 hour 8 minutes ago

Removal- Paragon Mortgages (No.28) PLC

Les Echos

Published on 12/22/2025 at 09:18, 49 minutes ago

GUILLEMOT CORPORATION: Information regarding the total number of voting rights and shares 11/12/2025
Published on 12/19/2025 at 08:30, 3 days 1 hour ago

Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 07:00, 3 days 3 hours ago

EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION
Published on 12/18/2025 at 18:30, 3 days 15 hours ago

Schneider Electric completes transaction to acquire remaining 35% stake in existing Indian JV
Published on 12/18/2025 at 17:45, 3 days 16 hours ago

Cie du Bois Sauvage : Cancellation of own shares

View all LES ECHOS COMFI WIRE